Japan’s global health leadership has a long legacy. The Government of Japan introduced global health as a key G8 agenda item for the first time in 2000 when the country hosted the G8 Summit. Since then, Japan has been a pioneering force behind forging transformational public-private partnerships including The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Innovative Technology (GHIT) Fund and the Coalition for Epidemic Preparedness Innovations (CEPI).
“[In 2019] Japan is very fortunate to serve the G20 Presidency and also host the 7th Tokyo International Conference on African Development… the world has high expectations for how the SDGs and development challenges can no longer be solved only by governments,” said Ambassador Tsuruoka. “Partnership between all sectors is crucial.”
A legacy of engagement in global child health
The Takeda Chair at LSHTM is emblematic of the company’s long-term commitment to the people and cutting-edge research bringing life-changing therapies to patients worldwide. Takeda’s Global CSR Program has been making long-term contributions to disease prevention, capacity building and access to healthcare in partnership with the global community for more than a decade. Furthermore, Takeda has supplied critical vaccines to the children of Japan for over 70 years, and more recently is working to expand impact on global health beyond Japan through a pipeline with the potential to transform the global picture for several neglected diseases.